New diabetes clinical trial: The Insulin-Only Bionic Pancreas Pivotal Trial | | |
New diabetes clinical trial: Very Low Carbohydrate Diets and Glucagon Response in T1DM | | |
New diabetes clinical trial: Effect of Probiotic Co-administration With Omega-3 Fatty Acids on Obesity Parameters and Insulin Resistance | | |
New diabetes clinical trial: The Impact of Different CSII and CGM Systems on Different Clinical Outcome Variables in Children and Adolescents With Type 1 Diabetes. An Observational Study Form the Norwegian Childhood Diabetes Registry (NCDR) | | |
New diabetes clinical trial: SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus | | Published on: December 17, 2019 at 07:00PM Condition: Type 1 Diabetes Interventions: Combination Product: Empagliflozin + Control-IQ x 4 wks then Basal-IQ x 2 wks; Combination Product: Empagliflozin + Basal-IQ x 2 wks then Control-IQ x 4 wks; Device: No Empagliflozin + Control-IQ x 4 wks then Basal-IQ x 2 wks; Device: No Empagliflozin + Basal-IQ x 2 wks then Control-IQ x 4 wks Sponsors: Ananda Basu, MD; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Tandem Diabetes Care, Inc.; DexCom, Inc. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04201496?term=diabetes&sfpd_d=14 December 17, 2019 at 05:08PM via ClinicalTrials.gov |
New diabetes clinical trial: Role of TLR2 and TLR4 in Stage 2 Periodontitis Patients With and Without Type 2 Diabetes: A Randomized Clinical Control Trial | | |
New diabetes clinical trial: Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes | | |
New diabetes clinical trial: Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1 | | |
New diabetes clinical trial: Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM | | |
New diabetes clinical trial: Pilot Clinical Evaluation: Sanvita Medical, LLC Continuous Glucose Monitoring System | | |
New diabetes clinical trial: Mobile Physical Activity for Type 1 Diabetes | | |
New diabetes clinical trial: iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes | | |
Няма коментари:
Публикуване на коментар